<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Guo CG</submitter><funding>Crohn's &amp; Colitis Foundation of America</funding><funding>NIDDK NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>428-435</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7821085</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(3)</volume><pubmed_abstract>&lt;h4>Importance&lt;/h4>Although aspirin is recommended for the prevention of colorectal cancer (CRC) among adults aged 50 to 59 years, recent data from a randomized clinical trial suggest a lack of benefit and even possible harm among older adults.&lt;h4>Objective&lt;/h4>To examine the association between aspirin use and the risk of incident CRC among older adults.&lt;h4>Design, setting, and participants&lt;/h4>A pooled analysis was conducted of 2 large US cohort studies, the Nurses' Health Study (June 1, 1980-June 30, 2014) and Health Professionals Follow-up Study (January 1, 1986-January 31, 2014). A total of 94 540 participants aged 70 years or older were included and followed up to June 30, 2014, for women or January 31, 2014, for men. Participants with a diagnosis of any cancer, except nonmelanoma sk</pubmed_abstract><journal>JAMA oncology</journal><pubmed_title>Aspirin Use and Risk of Colorectal Cancer Among Older Adults.</pubmed_title><pmcid>PMC7821085</pmcid><funding_grant_id>K01 DK120742</funding_grant_id><funding_grant_id>K07 CA218377</funding_grant_id><funding_grant_id>R35 CA197735</funding_grant_id><funding_grant_id>R01 CA137178</funding_grant_id><funding_grant_id>563526</funding_grant_id><funding_grant_id>P01 CA087969</funding_grant_id><funding_grant_id>690389</funding_grant_id><funding_grant_id>R01 CA151993</funding_grant_id><funding_grant_id>R35 CA253185</funding_grant_id><funding_grant_id>P01 CA055075</funding_grant_id><pubmed_authors>Ng K</pubmed_authors><pubmed_authors>Giovannucci EL</pubmed_authors><pubmed_authors>Chan AT</pubmed_authors><pubmed_authors>Joshi AD</pubmed_authors><pubmed_authors>Guo CG</pubmed_authors><pubmed_authors>Drew DA</pubmed_authors><pubmed_authors>Leung WK</pubmed_authors><pubmed_authors>Ma W</pubmed_authors><pubmed_authors>Ogino S</pubmed_authors><pubmed_authors>Song M</pubmed_authors><pubmed_authors>Cao Y</pubmed_authors><pubmed_authors>Meyerhardt JA</pubmed_authors><pubmed_authors>Nguyen LH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Aspirin Use and Risk of Colorectal Cancer Among Older Adults.</name><description>&lt;h4>Importance&lt;/h4>Although aspirin is recommended for the prevention of colorectal cancer (CRC) among adults aged 50 to 59 years, recent data from a randomized clinical trial suggest a lack of benefit and even possible harm among older adults.&lt;h4>Objective&lt;/h4>To examine the association between aspirin use and the risk of incident CRC among older adults.&lt;h4>Design, setting, and participants&lt;/h4>A pooled analysis was conducted of 2 large US cohort studies, the Nurses' Health Study (June 1, 1980-June 30, 2014) and Health Professionals Follow-up Study (January 1, 1986-January 31, 2014). A total of 94 540 participants aged 70 years or older were included and followed up to June 30, 2014, for women or January 31, 2014, for men. Participants with a diagnosis of any cancer, except nonmelanoma sk</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-18T15:11:02.216Z</modification><creation>2025-04-07T01:43:42.604Z</creation></dates><accession>S-EPMC7821085</accession><cross_references><pubmed>33475710</pubmed><doi>10.1001/jamaoncol.2020.7338</doi></cross_references></HashMap>